
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
`
+12
Founded in 2007, Curetis is a molecular diagnostics company whose mission is on the development and commercialization of reliable, fast and cost-effective syndromic testing products for the diagnosis of severe infectious diseases. The diagnostic solution Unyvero of Curetis enables rapid multi-parameter pathogen and antibiotic resistance marker detection in only a few hours, a process that today can take up to days or even weeks with the conventional techniques. The Unyvero diagnostic platform can be used for the diagnosis of hospitalized patients with several applications with the broadest panels to detect pathogens as the HPN (Hospitalized Pneumonia), BCU (Blood Culture Infection),...
Molecular diagnostics,medical devices,antibiotic resistances,infectious diseases,pathogens,pneumonia,implant and tissue infections,bloodstream infections,intra-abdominal infections,next-generation sequencing,syndromic testing,antimicrobial resistance,resistance marker,severe urinary tract infections,hospitalized infections,amr,and lower respiratory infections
Curetis gmbh operates in the Medical equipment manufacturing industry.
Curetis gmbh's revenue is 11m - 100m
Curetis gmbh has 11 - 50 employees.
Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.
Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.
Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.